Optimal adaptive cancer therapy based on evolutionary game theory
PLOS One · 23.04.2025 · 20 (4) · e0320677
DOI: 10.1371/journal.pone.0320677 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 23.04.2025. Verfasst von Zhiqing Li und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Mathematics and Computer Science, Yunnan Minzu University, Kunming, China. Hauptthemen laut MEDLINE: Game Theory, Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, the Youth Talent Program of Xingdian Talent Support Plan, the Yunnan Provincial Basic Research Program Project.
Abstract (Originalsprache)
Cancer development is a dynamic and continuously evolving process, with the emergence of drug-resistant cancer cells being one of the primary reasons for the failure of traditional treatments. Adaptive therapy, as an emerging cancer treatment strategy, is increasingly being applied in oncology. In this study, we incorporate pharmacokinetics into a cancer evolutionary game theory model and propose an optimal control problem constrained by maximum drug concentration and maximum tumor burden. Firstly, we demonstrate the existence of an optimal control for this problem. Secondly, using Pontryagin’s minimum principle, we formulated the structure of the optimal control to design an optimal adaptive therapy strategy. Finally, through numerical simulations, we compare the optimal adaptive therapy strategy with other adaptive therapies and traditional treatments, and further develop personalized treatment plans for different patient groups. The results demonstrate that the optimized adaptive treatment strategy effectively preserves a high survival rate of healthy cells during treatment. By maintaining drug-sensitive and drug-resistant cell populations in a state of low-level competition, this approach prevents the proliferation of drug-resistant cells, reduces the tumor burden on patients, and extends overall survival.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Mathematics and Computer Science, Yunnan Minzu University, Kunming, China.
ORCID-Profile: Zhiqing Li
Förderung
- National Natural Science Foundation of China
- the Youth Talent Program of Xingdian Talent Support Plan
- the Yunnan Provincial Basic Research Program Project
- the yunnan Province International Joint Laboratory for Intelligent Integration and Application of Ethnic Multilingualism
Zitieren
APA
Li, Z., Tan, X., & Yu, Y. (2025). Optimal adaptive cancer therapy based on evolutionary game theory. PLOS One, 20(4), e0320677. https://doi.org/10.1371/journal.pone.0320677
Vancouver
Li Z, Tan X, Yu Y. Optimal adaptive cancer therapy based on evolutionary game theory. PLOS One. 2025;20(4):e0320677. doi:10.1371/journal.pone.0320677
BibTeX
@article{Li2025,
author = {Li, Zhiqing and Tan, Xuewen and Yu, Yangtao},
title = {Optimal adaptive cancer therapy based on evolutionary game theory},
journal = {PLOS One},
year = {2025},
volume = {20},
number = {4},
pages = {e0320677},
doi = {10.1371/journal.pone.0320677}
}
EUVIMED